Who is eligible for routine prevention of hereditary angioedema attacks with Cinryze?

Cinryze is indicated for routine prevention in adults, adolescents and children aged 6 years and above with severe, recurrent hereditary angioedema attacks who cannot tolerate or are insufficiently protected by oral prevention treatments, or whose condition is inadequately managed with repeated acute treatment.